This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Francis Santens, PhD
Principal Scientist Molecular Engineering at Confo Therapeutics
Speaker

Profile

Francis Santens, PhD, is Principal Scientist Molecular Engineering at Confo Therapeutics, where he leads efforts in antibody engineering, formatting, humanization and analysis. Prior to joining Confo Therapeutics, he was Senior Scientist in Protein Engineering at Precirix, a biotech company developing targeted radiopharmaceuticals based on antibody-drug conjugates (ADCs). He obtained his PhD in protein engineering from Ghent University (VIB).

Agenda Sessions

  • Agonistic Antibodies for GPCR Modulation: Unlocking New Therapeutic Avenues in Obesity

    11:00am